G. Tkalcevic

发表

Genetic studies of kanamycin resistance in Campylobacter jejuni

P. Gemski, S. Kotarski, T. L. Merriwether, 1986, Antimicrobial Agents and Chemotherapy.

Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues.

P. Koza-Taylor, D. Petersen, T. A. Brown, 1998, Endocrinology.

Antiangiogenic and antitumor activity of a selective PDGFR tyrosine kinase inhibitor, CP-673,451.

Jing Lin, B. D. Cohen, J. Lyssikatos, 2005, Cancer research.

Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line.

S. Singh, G. Tkalcevic, N. Kamath, 1994, Biochemical pharmacology.

Molecular cloning of mouse hepatic triacylglycerol lipase: gene expression in combined lipase-deficient (cld/cld) mice.

R. Scow, W. Brown, G. Tkalcevic, 1991, Biochimica et biophysica acta.

Identification of Estrogen Receptor β2, A Functional Variant of Estrogen Receptor β Expressed in Normal Rat Tissues.

P. Koza-Taylor, D. Petersen, T. A. Brown, 1998, Endocrinology.

Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.

C. C. Jorgensen, Hao Sun, M. Boehm, 2015, Journal of medicinal chemistry.

, bone mass results in increased bone formation and osteoblast / osteocyte factor 45 gene ( OF 45 ) Targeted disruption of the Developmental Biology : Molecular Basis of Cell

J. Mcneish, H. Ke, T. A. Brown, 2002 .

Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.

P. Koza-Taylor, D. Petersen, T. A. Brown, 1998, Endocrinology.

Glutathione-linked detoxification pathway in normal and malignant human bladder tissue.

S. Singh, G. Tkalcevic, B. Xu, 1994, Cancer letters.

Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice.

S. Sebti, J. Jani, G. Tkalcevic, 1991, Cancer communications.

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.

M. Munchhof, A. Shavnya, N. Patel, 2012, ACS medicinal chemistry letters.

Discovery and synthesis of novel 4-aminopyrrolopyrimidine Tie-2 kinase inhibitors for the treatment of solid tumors.

Tracey Clark, Matthew D. Wessel, R. D. Connell, 2013, Bioorganic & medicinal chemistry letters.

Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.

S. Toler, M. J. Cole, D. Thompson, 1998, Journal of medicinal chemistry.

Identification of Osteoblast/Osteocyte Factor 45 (OF45), a Bone-specific cDNA Encoding an RGD-containing Protein That Is Highly Expressed in Osteoblasts and Osteocytes*

R. Rivera-Gonzalez, D. Petersen, T. A. Brown, 2000, The Journal of Biological Chemistry.

Targeted Disruption of the Osteoblast/Osteocyte Factor 45 Gene (OF45) Results in Increased Bone Formation and Bone Mass*

J. Stock, J. Mcneish, H. Ke, 2003, The Journal of Biological Chemistry.

Estrogen-induced genes in the uterus of ovariectomized rats and their regulation by droloxifene and tamoxifen

R. Rivera-Gonzalez, D. Petersen, D. Thompson, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871

Mark W Tengowski, Faye Wang, P. Miller, 2005, Clinical Cancer Research.

Structure and polymorphic map of human lipoprotein lipase gene.

K. Ishimura-Oka, W. Brown, K. Oka, 1990, Biochimica et biophysica acta.

Assessment of cholesteryl ester transfer protein inhibitors for interaction with proteins involved in the immune response to infection[S]

G. Karam, I. Wang, J. Boyd, 2010, Journal of Lipid Research.

Nucleotide sequence of PvuII polymorphic site at the human lipoprotein lipase gene locus.

D. Galton, J. Stocks, W. Brown, 1989, Nucleic acids research.

Discovery and preclinical pharmacology of a novel, potent, nonsteroidal estrogen receptor agonist/antagonist, CP-336156, a diaryltetrahydronaphthalene.

D. Thompson, Charles F. Ebbinghaus, G. Tkalcevic, 1998, Journal of medicinal chemistry.

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.

M. Munchhof, A. Shavnya, N. Patel, 2012, ACS medicinal chemistry letters.